RCUS Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Arcus Biosciences Inc

Watchlist Manager

Watchlist

Price: 29.51 USD -2.06% Market Closed

Market Cap: $3.7B

	Arcus Biosciences Inc NYSE:RCUS	US
	Deutsche Post AG F:DPWA	DE
F	First Tin PLC F:1SN	UK
	Vale SA BMV:VALEN	BR
	RTL Group SA F:RRTL	LU
	GomSpace Group AB F:1G2	SE
E	Empire Metals Ltd F:NOGN	UK
V	Vocera Communications Inc F:V00	US
	SITC International Holdings Co Ltd OTC:SITIF	HK

Profitability Summary

Arcus Biosciences Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-415%

Negative 3Y Average Operating Margin

-195%

Declining Operating Margin

-258% > -415%

Negative Net Margin

-393%

Negative 3Y Average Net Margin

-179%

Declining Net Margin

-237% > -393%

Negative Free Cash Flow Margin

-406%

Negative 3Y Average Free Cash Flow Margin

-185%

Declining Free Cash Flow Margin

-260% > -406%

Negative ROE

-91%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-171%

Declining ROIC

-113% > -301%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.